SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

An Atlas of Organisation of Lipids in Extracellular Vesicles To Navigate Their Roles in Cancer Metastasis

This project aims to create an atlas of asymmetric lipid compositions in cancer-derived extracellular vesicles to understand their role in metastasis using advanced imaging techniques.

Subsidie
€ 2.499.818
2024

Projectdetails

Introduction

It is estimated that up to 90% of cancer deaths are caused not by the primary cancer but after it has metastasised, i.e. spread to other organs in the body. It is well known that the locations of metastasised tumours are specific to the location of the primary cancer.

Role of Extracellular Vesicles

Communication and transfer of material between cells is a fundamental process in cell biology, for which nature uses extracellular vesicles (EVs). These nanometre-sized vesicles are excreted by cells and contain signature combinations of:

  • Membrane lipids
  • Nucleic acids
  • Proteins
  • Surface markers

EVs excreted by cancer cells play an important role in communication between tumours and distant organs where metastases can take hold.

Overlooked Aspects of EV Research

While more is now understood about the role of EV nucleic acids, proteins, and surface markers in these processes, the role of EV lipid composition, and especially the role of asymmetric lipid distribution across the membrane, remains overlooked.

Research Objectives

I address this fundamental research question by developing an interdisciplinary approach for mapping the asymmetric lipid composition of EVs with varying pro-metastatic nature from a library of cancer cell lines.

  1. I will create an atlas of asymmetric lipid compositions of EVs excreted by cancer cell lines.
  2. This atlas will include quantitative data on the asymmetric lipid distribution between the inner and outer membrane leaflets (asymmetric lipid distribution).

Methodology

To study the role of EV lipid composition on selective uptake in cells from the original tumour and pre-metastatic environment, I will apply neutron scattering and super-resolution microscopy techniques.

Significance of the Research

Taken together, the atlas of cancer-derived EV asymmetric lipid compositions that I will develop represents a significant advance to the state of the art. It will be a ground-breaking combination of cell biology with engineering-based tools for chemical and biophysical in-depth characterisation of complex, asymmetric membranes.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.818
Totale projectbegroting€ 2.499.818

Tijdlijn

Startdatum1-3-2024
Einddatum28-2-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • CHALMERS TEKNISKA HOGSKOLA ABpenvoerder

Land(en)

Sweden

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Oncolipidomics: Why is lipidomic dysregulation pattern in blood similar for various cancers?

The project aims to develop advanced lipidomic techniques to create a Cancer Lipidome Atlas, enhancing early cancer detection and treatment through comprehensive lipid profiling and data integration.

ERC Advanced...€ 3.499.413
2023
Details

Melanosomes as cancer immune modulators: a novel paradigm in melanoma immunity

This project aims to explore melanosomes' role in melanoma immunity to uncover new therapeutic strategies for treatment-resistant patients and enhance understanding of immune interactions.

ERC Advanced...€ 2.515.625
2024
Details

Regaining control of cancer at biological borders

BorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis.

ERC Advanced...€ 2.500.000
2024
Details

Decoding Extracellular Vesicle-mediated organ crosstalk in vivo

This project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease.

ERC Starting...€ 1.500.000
2023
Details

Proteomic Analysis of Cell communication in Tumors

This project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells.

ERC Consolid...€ 2.000.000
2022
Details
ERC Advanced...

Oncolipidomics: Why is lipidomic dysregulation pattern in blood similar for various cancers?

The project aims to develop advanced lipidomic techniques to create a Cancer Lipidome Atlas, enhancing early cancer detection and treatment through comprehensive lipid profiling and data integration.

ERC Advanced Grant
€ 3.499.413
2023
Details
ERC Advanced...

Melanosomes as cancer immune modulators: a novel paradigm in melanoma immunity

This project aims to explore melanosomes' role in melanoma immunity to uncover new therapeutic strategies for treatment-resistant patients and enhance understanding of immune interactions.

ERC Advanced Grant
€ 2.515.625
2024
Details
ERC Advanced...

Regaining control of cancer at biological borders

BorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis.

ERC Advanced Grant
€ 2.500.000
2024
Details
ERC Starting...

Decoding Extracellular Vesicle-mediated organ crosstalk in vivo

This project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease.

ERC Starting Grant
€ 1.500.000
2023
Details
ERC Consolid...

Proteomic Analysis of Cell communication in Tumors

This project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells.

ERC Consolidator Grant
€ 2.000.000
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

3D spheroids derived from single cells for discovering stochastic patterns behind metastasis

3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.

EIC Pathfinder€ 2.591.050
2023
Details

Geintegreerd systeem voor fractionering karakterisatie en kwantificatie van extracellulaire blaasjes en hun inhoud

Celnext Biotechnologies onderzoekt de haalbaarheid van een geïntegreerd microfluidisch systeem met optische biosensoren voor gestandaardiseerde isolatie en analyse van extracellulaire blaasjes (EBs).

Mkb-innovati...€ 20.000
2021
Details

Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering

The project aims to develop TAX2, a novel peptide therapy targeting the tumor microenvironment to inhibit solid tumor progression and enhance immunotherapy efficacy, with a focus on ovarian cancer.

EIC Accelerator€ 2.434.790
2025
Details

automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS

The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.

EIC Transition€ 2.497.750
2022
Details

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

EIC Pathfinder€ 2.982.792
2022
Details
EIC Pathfinder

3D spheroids derived from single cells for discovering stochastic patterns behind metastasis

3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.

EIC Pathfinder
€ 2.591.050
2023
Details
Mkb-innovati...

Geintegreerd systeem voor fractionering karakterisatie en kwantificatie van extracellulaire blaasjes en hun inhoud

Celnext Biotechnologies onderzoekt de haalbaarheid van een geïntegreerd microfluidisch systeem met optische biosensoren voor gestandaardiseerde isolatie en analyse van extracellulaire blaasjes (EBs).

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 20.000
2021
Details
EIC Accelerator

Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering

The project aims to develop TAX2, a novel peptide therapy targeting the tumor microenvironment to inhibit solid tumor progression and enhance immunotherapy efficacy, with a focus on ovarian cancer.

EIC Accelerator
€ 2.434.790
2025
Details
EIC Transition

automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS

The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.

EIC Transition
€ 2.497.750
2022
Details
EIC Pathfinder

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

EIC Pathfinder
€ 2.982.792
2022
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.